v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows used in operating activities:    
Net loss $ (1,547,912) $ (1,761,858)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 72,860 82,637
Stock based compensation 50,000 72,442
Amortization of right-of-use operating lease asset 75,625 72,270
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 79,879 164,031
Accounts payable and other current liabilities (626,991) (137,492)
Due to related parties 0 (206,967)
Net cash used in operating activities (1,896,539) (1,714,937)
Cash flows used in investing activities:    
Purchases of property and equipment (9,150) 0
Cash used in investing activities (9,150) 0
Cash flows provided (used in) by financing activities:    
Proceeds from the issuance of common stock 1,904,211 0
Payments for offering costs related to equity issuance exercises (82,568) 0
Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units and net stock option expense (4,488) (5,357)
Net cash provided (used in) by financing activities 1,817,155 (5,357)
Effect of exchange rate on changes on cash (4,123) (15,496)
Net decrease in cash, cash equivalents and restricted cash (92,657) (1,735,790)
Cash, cash equivalents and restricted cash at beginning of period 5,125,386 5,599,074
Cash, cash equivalents and restricted cash 5,032,729 3,863,284
Supplemental disclosures of non-cash investing and financing activities:    
Par value of shares issued for vested restricted stock units and net stock option exercise 0.03 0.0027
Deferred offering costs not yet paid 214,015 0
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets:    
Cash and cash equivalents 4,933,579 3,765,154
Restricted cash $ 99,150 $ 98,130